Word

Status

Registered

Status Code

700

Status Date

Tuesday, August 8, 2023

Serial Number

97294637

Registration Number

7130061

Registration Date

Tuesday, August 8, 2023

Mark Type

2000

Filing Date

Thursday, March 3, 2022

Published for Opposition

Tuesday, May 23, 2023

Trademark Owner History

Guangdong Jiyin Biology Co., Ltd. - Original Registrant

Classifications

5 Vaccines; Pharmaceutical preparations, namely, anti-infective preparations; Pharmaceutical preparations, namely, anti-viral preparations; Pharmaceutical preparations, namely, immunological preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, vaccine preparations; Diagnostic preparations for medical purposes; Blood derivatives, namely, hematology calibrators and controls, blood plasma, blood substitutes for human or veterinary use, coagulation factor, immunoglobulin, tissue type plasminogen activator, C-reactive protein, and human antithrombin; Enzymes for medical purposes

The mark consists of the design element of an incomplete hexagon with rounded corners. Contained within the hexagon are four lines, one of which has a shaded circle on its upper portion.
Color is not claimed as a feature of the mark.

Trademark Events

Aug 8, 2023

Notice Of Registration Confirmation Emailed

Aug 8, 2023

Registered-Principal Register

May 23, 2023

Official Gazette Publication Confirmation E-Mailed

May 23, 2023

Published For Opposition

May 3, 2023

Notification Of Notice Of Publication E-Mailed

Apr 17, 2023

Approved For Pub - Principal Register

Mar 20, 2023

Teas/Email Correspondence Entered

Mar 17, 2023

Correspondence Received In Law Office

Mar 17, 2023

Teas Response To Office Action Received

Dec 21, 2022

Notification Of Non-Final Action E-Mailed

Dec 21, 2022

Non-Final Action E-Mailed

Dec 21, 2022

Non-Final Action Written

Dec 14, 2022

Assigned To Examiner

Mar 9, 2022

Notice Of Design Search Code E-Mailed

Mar 8, 2022

New Application Office Supplied Data Entered

Mar 7, 2022

New Application Entered